This variant has been correlated with the rate of cognitive decline and AD progression (Franzmeier et al., 2021), increasing tau loads and contributing to poor cognitive performance and tau-related memory deficits (Franzmeier et al., 2019). Here, MAPT is linked to Alzheimer disease.